Log In
BCIQ
Print this Print this
 

ELI-202

  Manage Alerts
Collapse Summary General Information
Company Elite Pharmaceuticals Inc.
DescriptionAbuse deterrent-formulation of an undisclosed opioid agonist and naltrexone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPivotal
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today